Kazunori Murata - Concepedia

Author

Kazunori Murata

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

K Murata, K. Murata, Kazunori Murata, Kazunory Murata, Murata K

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Johns Hopkins University Sylvester Comprehensive Cancer Center National Cancer Institute University of Miami

About

Kazunori Murata is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	649
2	Cell Biology	3	3	273
3	Health Sciences	2	2	127
4	Public Health	1	1	44
5	Environmental Health	1	1	44

Kazunori Murata

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Relative Performance of the MDRD and CKD-EPI Equations for Estimating Glomerular Filtration Rate among Patients with Varied Clinical Presentations Kazunori Murata, N Baumann, Amy K. Saenger, Clinical Journal of the American Society of Nephrology	2011	177
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection Kazunori Murata, William M. Baldwin Transplantation Reviews Complement SystemSignal TransductionAutoimmune DiseaseMedicineImmunology	2009	128
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma Ola Landgren, Malin Hultcrantz, Benjamin Diamond, JAMA Oncology	2021	114
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey Ola Landgren, Barry I. Graubard, Shaji Kumar, Blood Cancer Journal	2017	110
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial Benjamin Diamond, Neha Korde, Alexander M. Lesokhin, The Lancet Haematology Hematological MalignancyOncologyContinuous Lenalidomide MaintenanceHematologyMyeloid Neoplasia	2021	87
In Vivo Platelet–Endothelial Cell Interactions in Response to Major Histocompatibility Complex Alloantibody Craig N. Morrell, Kazunori Murata, Anne Marie Swaim, Circulation Research Endothelial CellsImmunologyInflammationThrombosisHematology	2008	74
Synergistic Deposition of C4d by Complement‐Activating and Non‐activating Antibodies in Cardiac Transplants Kazunori Murata, Karen Fox-Talbot, Z. Qian, American Journal of Transplantation Complement SystemTransplantationSynergistic DepositionNon‐activating AntibodiesMedicine	2007	71
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood Kazunori Murata, Samuel I. McCash, Brittany L. Carroll, Clinical Biochemistry Hematological MalignancyBone Marrow FailureAutoimmune DiseaseMalignant Blood DisorderHematology	2016	67
C4d Deposition and Clearance in Cardiac Transplants Correlates With Alloantibody Levels and Rejection in Rats Koichiro Minami, Kazunori Murata, Chih‐Yuan Lee, American Journal of Transplantation Heart FailureXenotransplantationTransplantationMedicinePhysiology	2006	65
The Involvement of FcR Mechanisms in Antibody-Mediated Rejection Chih‐Yuan Lee, Sahar Lotfi‐Emran, Melek M. Erdinc, Transplantation	2007	65

Page 1